Punjab Chemicals closes FY26 with stronger margins and a clearer growth pipeline
Frequently Asked Questions
FY26 revenue from operations was 1029.8 crore, EBITDA was 118.1 crore (11.5% margin), and PAT was 64.0 crore (6.2% margin).
Q4 FY26 revenue was 208.6 crore (+3.1% YoY), EBITDA 27.5 crore (+7.9% YoY), and PAT 11.0 crore (+55.8% YoY).
Management stated new products contributed around 14% of FY26 revenue and grew 16% year on year.
Management reiterated guidance of 15% to 20% year-on-year revenue growth, subject to major geopolitical disruptions.
Management guided FY27 capex as 25 to 30 crore for maintenance/asset renewal, about 20 crore for debottlenecking/compliance/product mix, and 60 to 80 crore for a new production block, with any greenfield project being additional.
Management stated the three MoU products are slated for commercialization in FY27, with possible minor delays due to customer trials.
Management stated import dependency for raw materials from various geographies including China is about 25%, with the balance sourced domestically.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
